Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer.
Saved in:
| Title: | Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer. |
|---|---|
| Authors: | Zhang Y; Department of Breast Surgery, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Liu L; Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China., Bao H; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China., Xu K; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China., Zhang H; Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, China.; Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China., Wang S; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China., Chang S; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China., Zhu D; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China., Huang Z; Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China., Wang Z; Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China., Yang L; Colorectal Center, Jiangsu Cancer Hospital, Nanjing, China., Zhang B; Department of Gynecologic Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China., Tao J; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Liang W; Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China., Chen J; Department of Clinical Laboratory, Guangdong Provincial People's Hospital, Guangzhou, China., Yang S; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China., Wu X; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China., Shao Y; Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China. yang.shao@geneseeq.com.; School of Public Health, Nanjing Medical University, Nanjing, China. yang.shao@geneseeq.com., Wang W; Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. wang.wenquan@zs-hospital.sh.cn., Zhu D; Department of Rare Tumors, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. zhudy@sd-cancer.com. |
| Source: | Molecular biomedicine [Mol Biomed] 2026 Aug 05; Vol. 7 (1). Date of Electronic Publication: 2026 Aug 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 9918283581406676 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-8651 (Electronic) Linking ISSN: 26628651 NLM ISO Abbreviation: Mol Biomed Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
